A good-news story from The Guardian about Tofersen, an antisense oligonucleotide for ALS/MND (i.e. not for PD)

[jeffreyn]

"The FDA is considering an application to license the drug and it is being offered to patients in the UK under an early access programme."

Experimental drug shows signs of slowing motor neurone disease:

theguardian.com/society/202...

For an introduction to antisense oligonucleotides, see this SoPD blog post from Simon.

Making sense of antisense:

scienceofparkinsons.com/201...